Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Deferred Taxes: 2010-2024

Historic Deferred Taxes for Myriad Genetics (MYGN) over the last 14 years, with Dec 2024 value amounting to $200,000.

  • Myriad Genetics' Deferred Taxes rose 108.70% to $200,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$2.8 million, marking a year-over-year increase of 30.00%. This contributed to the annual value of -$2.8 million for FY2024, which is 30.00% up from last year.
  • Latest data reveals that Myriad Genetics reported Deferred Taxes of $200,000 as of Q4 2024, which was up 114.29% from -$1.4 million recorded in Q3 2024.
  • Over the past 5 years, Myriad Genetics' Deferred Taxes peaked at $49.0 million during Q2 2020, and registered a low of -$48.4 million during Q3 2020.
  • For the 3-year period, Myriad Genetics' Deferred Taxes averaged around -$3.1 million, with its median value being -$1.8 million (2024).
  • As far as peak fluctuations go, Myriad Genetics' Deferred Taxes skyrocketed by 2,385.71% in 2020, and later slumped by 1,666.67% in 2022.
  • Myriad Genetics' Deferred Taxes (Quarterly) stood at -$44.2 million in 2020, then surged by 90.27% to -$4.3 million in 2021, then slumped by 104.65% to -$8.8 million in 2022, then soared by 73.86% to -$2.3 million in 2023, then surged by 108.70% to $200,000 in 2024.
  • Its Deferred Taxes was $200,000 in Q4 2024, compared to -$1.4 million in Q3 2024 and -$2.2 million in Q2 2024.